{"id":"NCT03158688","sponsor":"Amgen","briefTitle":"Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.","officialTitle":"A Randomized, Open-label, Phase 3 Study Comparing Carfilzomib, Dexamethasone, and Daratumumab to Carfilzomib and Dexamethasone for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-06-13","primaryCompletion":"2019-07-14","completion":"2022-04-15","firstPosted":"2017-05-18","resultsPosted":"2020-09-11","lastUpdate":"2025-05-09"},"enrollment":466,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Relapsed Multiple Myeloma","Refractory Multiple Myeloma"],"interventions":[{"type":"DRUG","name":"Dexamethasone","otherNames":[]},{"type":"DRUG","name":"Daratumumab","otherNames":["DARZALEX®"]},{"type":"DRUG","name":"Carfilzomib","otherNames":["KYPROLIS®"]}],"arms":[{"label":"Kd - Carfilzomib and Dexamethasone","type":"ACTIVE_COMPARATOR"},{"label":"KdD - Carfilzomib, Dexamethasone and Daratumumab","type":"EXPERIMENTAL"}],"summary":"Compare carfizomib, dexamethasone, and daratumumab (KdD) to Carfilzomib and dexamethasone (Kd) in terms of progression free survival (PFS) in participants with multiple myeloma who have relapsed after 1 to 3 prior therapies.","primaryOutcome":{"measure":"Progression-free Survival (PFS) as Assessed by the Independent Review Committee (PA DCO Only)","timeFrame":"From randomization until the PA DCO date of 14 July 2019; the longest treatment duration as of the DCO was 102.3 weeks","effectByArm":[{"arm":"Kd - Carfilzomib and Dexamethasone","deltaMin":68,"sd":null},{"arm":"KdD - Carfilzomib, Dexamethasone and Daratumumab","deltaMin":110,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0014"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":9},"locations":{"siteCount":113,"countries":["United States","Australia","Austria","Belgium","Bulgaria","Canada","Czechia","France","Greece","Hungary","Japan","Poland","Romania","Russia","South Korea","Spain","Taiwan","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["34046887","34180331","34410635","34871550","35608261","32682484","33112184","37163358","40087058"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":80,"n":153},"commonTop":["Thrombocytopenia","Anaemia","Hypertension","Upper respiratory tract infection","Diarrhoea"]}}